Literature DB >> 3940191

Relationship of mitochondrial function and cellular adenosine triphosphate levels to hematoporphyrin derivative-induced photosensitization in R3230AC mammary tumors.

R Hilf, R S Murant, U Narayanan, S L Gibson.   

Abstract

The effects of hematoporphyrin derivative-induced photosensitization on the levels of adenosine triphosphate (ATP) in R3230AC mammary adenocarcinomas were studied. Enzymatically dissociated tumor cells were exposed to various doses of hematoporphyrin derivative (HPD) in vitro plus photoradiation. A drug and light dose-dependent decrease in cellular ATP levels was observed; ATP levels were reduced by 60% after treatment with 7.0 micrograms HPD per ml plus 0.72 J total energy density per cm2. Cell viability, assessed by exclusion of trypan blue, displayed an apparently coordinate behavior to ATP levels. The effects of hematoporphyrin derivative plus photoradiation were examined in the presence of oligomycin, an inhibitor of mitochondrial oxidative phosphorylation, or iodoacetate, an inhibitor of glycolysis, experiments designed to elucidate the site of action leading to reduced ATP levels. The results indicated that HPD-induced photosensitization had little additive effects to oligomycin-sensitive ATP production, whereas significant further reduction in ATP levels was obtained by HPD-induced photosensitization in the presence of iodoacetate. Taken together, along with earlier studies of selected mitochondrial enzymes, we conclude that HPD plus photoradiation inhibits mitochondrial function leading to reduction in cellular ATP levels and loss of viability.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3940191

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  21 in total

1.  Response of human endometrium and ovarian carcinoma cell-lines to photodynamic therapy.

Authors:  G H Raab; A F Schneider; W Eiermann; H Gottschalk-Deponte; R Baumgartner; W Beyer
Journal:  Arch Gynecol Obstet       Date:  1990       Impact factor: 2.344

2.  Lipid peroxidation induced by a novel porphyrin plus light in isolated mitochondria: possible implications in photodynamic therapy.

Authors:  S R Chatterjee; T S Srivastava; J P Kamat; T P Devasagayam
Journal:  Mol Cell Biochem       Date:  1997-01       Impact factor: 3.396

Review 3.  Is there a measure for low power laser dose?

Authors:  Adenilson de Souza da Fonseca
Journal:  Lasers Med Sci       Date:  2018-11-06       Impact factor: 3.161

4.  Photodynamic effects of haematoporphyrin derivative on DNA repair in murine L929 fibroblasts.

Authors:  J P Boegheim; T M Dubbelman; L H Mullenders; J Van Steveninck
Journal:  Biochem J       Date:  1987-06-15       Impact factor: 3.857

5.  Photodynamic tumor therapy: mitochondrial benzodiazepine receptors as a therapeutic target.

Authors:  A Verma; S L Facchina; D J Hirsch; S Y Song; L F Dillahey; J R Williams; S H Snyder
Journal:  Mol Med       Date:  1998-01       Impact factor: 6.354

6.  A novel mechanism for the generation of superoxide anions in hematoporphyrin derivative-mediated cutaneous photosensitization. Activation of the xanthine oxidase pathway.

Authors:  M Athar; C A Elmets; D R Bickers; H Mukhtar
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

7.  Opposite effects of Mn(III) and Fe(III) forms of meso-tetrakis(4-N-methyl pyridiniumyl) porphyrins on isolated rat liver mitochondria.

Authors:  M F Nepomuceno; M Tabak; A E Vercesi
Journal:  J Bioenerg Biomembr       Date:  2002-02       Impact factor: 2.945

8.  Role of oxygen vs. glucose in energy metabolism in a mammary carcinoma perfused ex vivo: direct measurement by 31P NMR.

Authors:  C J Eskey; A P Koretsky; M M Domach; R K Jain
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

9.  Uptake and phototoxic effects of aluminum-chlorophthalocyanine (AlSPc) in human bladder carcinoma cells.

Authors:  K Miller; E Reich; T Grau; R Hautmann
Journal:  Urol Res       Date:  1994

Review 10.  Photobiomodulation for the treatment of retinal diseases: a review.

Authors:  Ivayla I Geneva
Journal:  Int J Ophthalmol       Date:  2016-01-18       Impact factor: 1.779

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.